Mika Health, Cancer Support Community partner on AI oncologic digital therapeutic

The article discusses a partnership between Mika Health, an oncology-focused digital therapeutics company, and the Cancer Support Community (CSC) to provide an AI-enabled digital therapeutic for U.S.-based cancer patients and their caregivers. The digital therapeutic aims to offer mental health and other support services free of charge, including psychological support, medication tracking, reminders, education, nutrition advice, and appointment coordination. The app is personalized to an individual’s specific type of cancer and has been certified as a medical device in the EU, with plans to make it available to patients in North America. The collaboration between Mika Health and CSC also includes expanding access to the app through healthcare partnerships and network locations, creating multicultural and multilingual components to improve health equity, and conducting research on psychosocial patient behaviors and treatments.
Highlights:
1. Mika Health and Cancer Support Community partner to offer an AI-enabled oncology-focused digital therapeutic for cancer patients and caregivers.
2. The digital therapeutic provides mental health support, medication tracking, education, nutrition advice, and appointment coordination, tailored to individual cancer types.
3. The collaboration includes plans to expand access, improve health equity with multicultural components, and conduct research on psychosocial patient behaviors and treatments.
Summary:
The article details the partnership between Mika Health and Cancer Support Community to provide a personalized AI-enabled digital therapeutic for cancer patients in the U.S., offering a range of support services free of charge. The collaboration aims to improve mental health, medication management, and overall care coordination for individuals impacted by cancer while also working towards expanding access, promoting health equity, and conducting research to enhance patient and caregiver outcomes.
Editorial content by NewsSIP AI